Completed PHASE2 INTERVENTIONAL 3-arm NCT00816101

Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation

Efficacy of the PROCELLERA™ Wound Dressing in the Healing of Wounds After a Curettage and Electrodesiccation of Skin Lesions

Sponsor: Vomaris Innovations

Conditions Acute Wounds

Interventions Adhesive Bandage Mepilex® Border Lite Procellera™ Antimicrobial Dressing

Updated 8 times since 2017 Last updated: Mar 4, 2011 Started: Mar 31, 2008 Primary completion: Sep 30, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00816101, this PHASE2 trial focuses on Acute Wounds and remains completed. Sponsored by Vomaris Innovations, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vomaris Innovations

Data source: Vomaris Innovations

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tucson, United States